español

Publications about Bioenergetic Signature

  • Cuezva et al., (2002). The bioenergetic signature of cancer: a marker of tumor progression. Cancer Research U62U, 6674-6681.
  • Isidoro A. et al. (2004). Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J. U378U, 17-20.
  • Cuezva et al. (2004). The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis U25U, 1157-1163.
  • Young-Kyoung Shin et al (2005). Down-regulation of Mitochondrial F1F0-ATP Synthase in Human Colon Cancer Cells with induced 5- Fluorouracil Resistance. Cancer Research U65U, 3162-3170.
  • Isidoro A. et al. (2005). Breast carcinomas fulfil the Warburg’s hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis U26U, 2095-2104.
  • Santamaría et al., (2006) Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of the H+-ATP synthase. Carcinogenesis U27U, 925-935.
  • López-Ríos et al. (2007) Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Research U67U.

© 2013 Fina Biotech. Madrid. Tel +34 917 991 564 info@finabiotech.es

Enlaces a redes sociales